Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12731847 | 0.80 | KDM4E (0.58) | ALOX5KMT2AACHEKDM4EALDH1A1 | |
| SCHEMBL4234480 | 0.78 | LPAR3 (0.69) | ALOX5KMT2AKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL7504758 | 0.77 | ALOX5 (0.57) | ALOX5KMT2AACHEKDM4EALDH1A1 | |
| SCHEMBL1122540 | 0.76 | ALOX5 (0.53) | ALOX5KMT2AACHEKDM4EALDH1A1 | |
| SCHEMBL14876485 | 0.76 | ALOX5 (0.56) | ALOX5KMT2AKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL28639253 | 0.76 | ALOX5 (0.62) | ALOX5KMT2AACHEKDM4EALDH1A1 | |
| SCHEMBL6207633 | 0.76 | ALOX5 (0.62) | ALOX5ACHEKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL30070354 | 0.76 | ALOX5 (0.62) | ALOX5ACHEKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL522710 | 0.74 | PIN1 (0.62) | ALOX5KMT2AKDM4EALDH1A1L3MBTL1 | |
| SCHEMBL8686545 | 0.74 | ALOX5 (0.57) | ALOX5KMT2AACHEKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190225591-A1 | PROCESS FOR PREPARING 5-PHENOXY-1(3)ISOBENZOFURANONE | KINGCHEM LIFE SCIENCE LLC | 2019-07-25 | — | — | US | disclosed |
| WO-2018140186-A1 | A PROCESS FOR PREPARING 5-PHENOXY-1(3H)ISOBENZOFURANONE | KINGCHEM LIFE SCIENCE LLC (US) | 2018-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225591-A1 | PROCESS FOR PREPARING 5-PHENOXY-1(3)ISOBENZOFURANONE | PPOX, KCNA5, KCNH2 | ALOX5 1076/4885KMT2A 622/4885ACHE 1149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.